Home
Live Updates
Argá Medtech Initiates First-in-Human Trial to Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation : vimarsana.com
Argá Medtech Initiates First-in-Human Trial to Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation
Acute procedural success achieved in all patients using a novel pulsed field ablation (PFA) sine waveform and configurable catheter. EPALINGES, Switzerland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Argá Medtech
Related Keywords
San Diego ,
California ,
United States ,
Tbilisi ,
Georgia General ,
Georgia ,
,
Epalinges ,
Switzerland General ,
Switzerland ,
Croatia ,
Giorgi Papiashvili ,
David Neale ,
Ante Anic University Hospital ,
Healthycore Medical Center ,
First In Human Clinical Trial ,
Sine Burst Electroporation ,
System Pilot Study ,
Atrial Fibrillation ,
Ante Anic ,
University Hospital Split ,
Arg 225 ,
Edtech ,
Nitiates ,
Irst ,
Uman ,
Rial ,
Ssess ,
Afety ,
Ffectiveness ,
Oherent ,
Ine ,
Ave ,
Lectroporation ,
Atients ,
Trial ,
Ibrillation ,
vimarsana.com © 2020. All Rights Reserved.